|
Emmerson, P J; Archer, S; El-Hamouly, W et al. (1997) Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor. Biochem Pharmacol 54:1315-22
|
|
Archer, S; Glick, S D; Bidlack, J M (1996) Cyclazocine revisited. Neurochem Res 21:1369-73
|
|
Jiang, Q; Seyed-Mozaffari, A; Sebastian, A et al. (1995) Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism. J Pharmacol Exp Ther 273:680-8
|
|
Jiang, Q; Sebastian, A; Archer, S et al. (1994) 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists J Pharmacol Exp Ther 268:1107-13
|
|
Jiang, Q; Sebastian, A; Archer, S et al. (1993) 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties. Eur J Pharmacol 230:129-30
|
|
Jiang, Q; Seyed-Mozaffari, A; Archer, S et al. (1993) Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO). J Pharmacol Exp Ther 264:1021-7
|
